VOYA Investment Management’s Starling Oncology STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$82.2K Buy
15,145
+1,812
+14% +$7.61K ﹤0.01% 2376
2026
Q1
$40.9K Buy
13,333
+1,487
+13% +$4.56K ﹤0.01% 2295
2025
Q4
$42.2K Buy
11,846
+928
+8% +$3.44K ﹤0.01% 2352
2025
Q3
$38.1K Sell
10,918
-6,073
-36% -$20.8K ﹤0.01% 2404
2025
Q2
$34.8K Buy
+16,991
New +$42.5K ﹤0.01% 2639
2022
Q4
Sell
-13,781
Closed -$63.8K 2944
2022
Q3
$63.8K Buy
+13,781
New +$81K ﹤0.01% 2868

Other funds holding STLN

VOYA Investment Management's STLN Position: Q2 2026 in Review

VOYA Investment Management increased its Starling Oncology (STLN) stake by 14% in Q2 2026, buying an estimated $7.61K and bringing the position to 15,145 shares worth $82.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

VOYA Investment Management first reported a position in STLN in Q3 2022 and has held it in 6 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • VOYA Investment Management held 15,145 shares of Starling Oncology worth $82.2K as of Q2 2026.
  • VOYA Investment Management bought 1,812 Starling Oncology shares in Q2 2026, an estimated $7.61K.
  • Starling Oncology made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2376 holding.
  • VOYA Investment Management first reported a position in Starling Oncology in Q3 2022 and has held it in 6 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.